![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » Veeva Systems updates Veeva Vault
Veeva Systems updates Veeva Vault
November 19, 2014
Veeva Systems, based in Pleasanton, Calif., has released Veeva Vault innovations. Individuals across the organization can share and reuse approved content, eliminating manual hand-offs and duplicate work. At the same time, Vault provides local autonomy and flexibility for each department or region to manage its own content to reflect its unique business processes. Vault maintains one authoritative source document in the cloud to bridge content gaps, increasing efficiency, visibility and compliance.
This new Vault release brings the global life sciences organization together, including therapeutic areas, regional affiliates, investigator sites and sales and marketing groups worldwide, which were historically served by separate solutions that didn’t interoperate. Most life sciences companies continue to struggle managing multiple, isolated legacy systems, resulting in manual document handoffs, inefficiencies and compliance risk. Conservative estimates show these inefficiencies contribute to an average of 21% loss in productivity.
“A simple protocol change in today’s siloed environment may involve more than 25 steps, leveraging multiple copies of a document across multiple systems,” said Jennifer Goldsmith, vice president of Veeva Vault. “With Vault, we decrease this to one single source, just eight steps, cutting the time required to execute the update from weeks to minutes to dramatically reduce cost and compliance risk.”
Documents are cross-linked across Vault applications, so the same content is used in a different context—whether in a submission, trial master file or promotional piece—making the document easier to organize and access for different users but traceable to ensure a controlled, single source of truth. For example, a protocol may be authored by the regulatory team, incorporated into a clinical trial master file and then distributed to investigator sites, so it’s needed in three different contexts. With Vault, one document is used across all of these areas, upholding a clear chain of custody. Teams reuse materials with confidence, knowing that they’re always working with the right version.
Upcoming Events
-
21Oct